Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A16AX Various alimentary tract and metabolism products
A16AX18 Lumasiran
D11926 Lumasiran sodium <US>
USP drug classification [BR:br08302]
Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
Lumasiran
D11926 Lumasiran sodium
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Oxidases
HAO1
D11926 Lumasiran sodium <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11926
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D11926
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11926
Pharmacogenomic biomarkers [br08341.html]
Germline mutations in genetic disorder treatments
D11926
